Percutaneous Interventional Cardiovascular Medicine Ebook

9782913628571.1.jpg
9782913628571.1.jpg

Percutaneous Interventional Cardiovascular Medicine Ebook

250.00

Contributors: Eric Eeckhout, Patrick W. Serruys
Publisher: PCR Publishing
Published 2012-08
eBook List Price: $250.00


***Your ebook access code will be sent from info@cardiotext.com. If you do not receive your access code the next business day, please be sure to check in your spam/junk folders. ***

Quantity:
Add To Cart
The PCR-EAPCI Textbook
Percutaneous Interventional Cardiovascular Medicine
Edited by Eric Eeckhout, Patrick W. Serruys, William Wijns, Alec Vahanian, Marc van Sambeek, Rodney De Palma

"By and for" the interventional community and dedicated to the patients they serve
A Textbook made by and for the community.

The PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook is a first of its kind, all-inclusive reference whose scope and content is patient-centred and promotes good, evidence-based clinical practices.

It is poised to become the reference for interventional practitioners. There are four volumes dedicated to diagnosis, coronary interventions, structural heart disease, peripheral interventions and perspectives.

Both clinically and practically oriented, the Textbook covers all you need to know as an international cargiologist.

The digital version makes this Textbook an evolving encyclopaedia of interventional wisdom to be shared, questioned, criticised and improved by you, the reader.

Table of Contents:

VOLUME I — Diagnosis

From the editors: Introducing the digital edition of The PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook

Foreword: A European touch

Foreword: Why a textbook? Why this textbook?

Preface: PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook: a step and benchmark for a future model in education

Introduction: Bringing it all together, the Genesis of the PCR EAPCI textbook

Part I — Foundations of interventional cardiovascular medicine

1.1 - A history of cardiac catheterisation

1.2 - A history of percutaneous coronary intervention

1.3 - Right and left heart catheterisation

1.4 - Vascular access

1.5 - Vascular closure

1.6 - Cardiac transseptal catheterisation

1.7 - Catheterisation for peripheral diagnostic and interventional procedures

1.8 - Cardiac catheterisation in children and adults with grown-up congenital heart disease

1.9 - Endomyocardial biopsy

1.10 - Pericardiocentesis

1.11 - Percutaneous ventricular assistance

1.12 - Radiation protection

1.13 - Contrast agents and renal protection

1.14 - Sedation, pain management and resuscitation

1.15 - Biostatistics for the interventionist

Part II — Diagnostic cardiovascular modalities and their application

2.1 - Cardiac biomarkers

2.2 - Fundamentals of coronary biomechanics

2.3 - Non-invasive imaging for coronary disease

2.4 - Non-invasive imaging for structural heart disease

2.5 - Imaging for peripheral artery disease

2.6 - Invasive diagnostic coronary angiography

2.7 - Invasive haemodynamic assessment

2.8 - Invasive physiological assessment of coronary disease

2.9 - Assessment of coronary vasoreactivity and the microcirculation

2.10 - Intracardiac echocardiography

2.11 - Intravascular ultrasound

2.12 - Optical coherence tomography

2.13 - Near-infrared spectroscopy

VOLUME II — Intervention I

Part III — Percutaneous interventions for cardiovascular disease

3.1 - Guide catheters and wires

3.2 - Balloon angioplasty technology

3.3 - Coronary artery stents

3.4 - Bioresorbable scaffolds

3.5 - Drug-coated balloons

3.6 - Rotational atherectomy

3.7 - Directional atherectomy

3.8 - Laser therapy

3.9 - Distal protection and thrombectomy

3.10 - Bifurcation lesions

3.11 - Ostial lesions

3.12 - Left main coronary artery disease

3.13 - Chronic total occlusions

3.14 - Saphenous vein graft disease

3.15 - Risk stratification and risk models in revascularisation

3.16 - Interventions for stable coronary disease

3.17 - Interventions for ST-segment elevation acute myocardial infarction

3.18 - Interventions for non-ST-segment elevation acute coronary syndromes

3.19 - Interventions for patients with diabetes mellitus

3.20 - Interventions for patients with chronic renal disease

3.21 - Secondary revascularisation

3.22 - Hybrid interventions

3.23 - Cardiogenic shock

3.24 - The prevention and management of complications during percutaneous coronary intervention

3.25 - Stent thrombosis

3.26 - In-stent restenosis

3.27 - Peri-procedural and post-procedural antithrombotic pharmacotherapy

3.28 - Secondary prevention and follow-up

VOLUME III — Intervention II

Part III — Percutaneous interventions for cardiovascular disease

3.29 - Percutaneous interventions in mitral and tricuspid stenosis and in failure of mitral and tricuspid bioprostheses

3.30 - Percutaneous mitral valve repair

3.31 - Balloon aortic valvuloplasty

3.32 - Transcatheter aortic valve implantation

3.33 - Percutaneous pulmonary valvuloplasty

3.34 - Percutaneous pulmonary valve implantation

3.35 - Atrial septal defect and patent foramen ovale closure

3.36 - Ventricular septal defect closure

3.37 - Patent ductus arteriosus closure

3.38 - Left atrial appendage occlusion

3.39 - Coarctation of the aorta

3.40 - Interventions for congenital and acquired pulmonary vein stenosis

3.41 - Percutaneous closure of paravalvular leaks

3.42 - Carotid artery stenting

3.43 - Subclavian, brachiocephalic and vertebral interventions

3.44 - Thoracic and abdominal aortic disease

3.45 - Interventions in the reno-visceral circulation

3.46 - Peripheral arterial occlusive disease

3.47 - Interventions for varicose veins

3.48 - Closure of arteriovenous fistulae and malformations

3.49 - Alcohol septal ablation for hypertrophic obstructive cardiomyopathy

3.50 - Alternative techniques to alcohol septal ablation for hypertrophic obstructive cardiomyopathy

3.51 - Renal sympathetic denervation

3.52 - Techniques of myocardial stem cell delivery

3.53 - Cell-based regenerative therapy

3.54 - Pulmonary embolism and pulmonary hypertension

VOLUME IV — Perspective

Part IV — Interventional cardiovascular medicine into context

4.1 - The Heart team

4.2 - Patient information, ethics, and informed consent

4.3 - The cardiac catheterisation laboratory environment

4.4 - Administration and data collection

4.5 - Registry studies and post-marketing surveillance

4.6 - Clinical trial design

4.7 - Quality of life assessment

4.8 - Risk-benefit analysis

4.9 - Cost and cost-effectiveness

4.10 - Interventional cardiology training

4.11 - Consensus on definitions of clinical endpoints : percutaneous coronary and valvular intervention trials

4.12 - Consensus on definitions of clinical endpoints : carotid artery and supra-aortic trunk revascularisation trials

Part V — Annexes

5.1 - Interventional pharmacology

5.2 - Interventional innovation landscape

5.3 - ARC definitions of clinical endpoints for interventional trials

5.4 - Cardiology audit and registration data standards

5.5 - Abridged ESC guidelines for interventional practice

5.6 - The global burden of cardiovascular disease